94219 ⎘
Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms; Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom; Oxygen atoms Ketonic radicals
PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS
#2SQUARAMIDE DERIVATIVES AS CB1 ALLOSTERIC MODULATORS
#3SMALL MOLECULE ANTAGONISTS OF PF4
#4ESTROGENIC COMPOUNDS AND METHODS OF USE
#5PROCESS FOR PREPARING ((1S,2S)-2-(5-METHYLPYRIDIN-2-YL)CYCLOPROPYL)METHANOL
#6NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
#7CURCUMIN ANALOGUES AS ZINC CHELATORS AND THEIR USES
#8INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY
#9TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS
#10CURCUMIN ANALOGUES AS ZINC CHELATORS AND TEHIR USES
#11ARYLMETHYLENE AROMATIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#12γ-diketones as Wnt/β-catenin signaling pathway activators
#13NAPHTHOQUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISORDERS
#14COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS
#15NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
#16Synthetic Antibacterial Compounds and Uses Thereof
#17Inhibitors of the WNT/beta-catenin pathway
#18ß- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORS
#19COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION
#204-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#21Complexes
#22Method for preparing 3-[(3S)-7-bromo-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-[1,4]-benzodiazepin-3-yl] propionic acid methyl ester, and compounds useful in that method
#23Curcumin analogues as zinc chelators and their uses
#24Inhibitors of lysine gingipain
#25Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices
#26NADPH oxidase inhibitors and uses thereof
#27Gamma-diketones as wnt/β-catenin signaling pathway activators
#28Compound used as autophagy regulator, and preparation method therefor and uses thereof
#29Modulators of hemoglobin
#30COMPOUND HAVING ENHANCING ACTIVITY FOR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR ACTIONS
#31B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
#32Method for preparing chromium(III) pyridine-2-carboxylate using 2-OP rectification residues
#33Syntheses of allyl phosphine complexes of palladium
#34Chemoselective methylene hydroxylation in aromatic molecules
#35NUCLEAR TRANSPORT MODULATORS AND USES THEREOF
#36Compounds useful as modulators of TRPM8
#37Inhibitors of lysine gingipain
#384-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#39Allyl phosphine complexes of palladium and their use in catalysis
#40Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
#41Antifungal compound process
#42Antifungal compound process
#43Antifungal Compound Process
#44Antifungal compound process
#45γ-diketones as Wnt/β-catenin signaling pathway activators
#46Antifungal compound process
#47In Vivo Methods for Enhancing Bioenergetic Status in Female Germ Cells
#48Inhibitors of lysine gingipain
#49β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators
#50Aromatic surfactants
#51Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer
#52Method of producing organic compound
#53Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
#542-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
#55Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#56Aryl sulfonamides
#57Compounds useful as modulators of TRPM8
#58Inhibitors of lysine gingipain
#59Use of particular pyridinium salts for the treatment of keratin substances, compositions and implementation methods
#60Process for the synthesis of metyrapone and alkylated metyrapone analogs
#614-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#62Herbicidal compounds
#63Compounds for the treatment of paramyxovirus viral infections
#64Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
#65γ-diketones as Wnt/β-catenin signaling pathway activators
#66Stabilized compositions and methods of manufacture
#67Pharmaceutical composition containing verbenone derivative for treating or preventing neurodegenerative disease
#682-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation
#69Curcumin analogues as zinc chelators and their uses
#70Nuclear Transport Modulators And Uses Thereof
#71Complexes
#72Antifungal compound process
#73Antifungal compound process
#74Antifungal compound process
#75Antifungal compound process
#76Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
#77COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
#78Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
#79Slow release of organoboronic acids in cross-coupling reactions
#80Methods of promoting wound healing using CRM1 inhibitors
#81MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#82Substituted quinoxaline derivatives as pest control agent
#83Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
#84Substituted pyridines as sodium channel blockers
#85Herbicidally active 2-(substituted-phenyl)-cyclopentane-1,3-dione compounds and derivatives thereof
#86Inhibitors of lysine gingipain
#87Synthetic analogues of xanthohumol
#884-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#89Triazole derivatives
#90CCR9 INHIBITORS AND METHODS OF USE THEREOF
#91Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl)-(2-chlorophenyl)-methanone
#92Metal-catalyzed coupling of aryl and vinyl halides with alpha, alpha-difluorocarbonyl compounds
#93Triazole derivatives
#94THERAPEUTIC CURCUMIN DERIVATIVES
#95Curcumin analogues as zinc chelators and their uses
#96Compositions and Methods for Enhancing Bioenergetic Status in Female Germ Cells
#97Carboxamide compounds
#98Compounds useful as modulators of TRPM8
#99Process for preparing 3-[(45)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
#100Oxidisable pyridine derivatives, their preparation and use as anti-alzheimer agents
#101Herbicidally active cyclic dione compounds, or derivatives therefor, substituted by a phenyl which has an alkynyl-containing substituent
#102β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators
#103β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators
#104Pyridine compounds and the uses thereof
#105Compounds for the treatment of paramoxyvirus viral infections
#106PROCESS FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS
#107Process for preparing a ketosulfone derivative
#108Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#109Aryl sulfonamides
#110CHEMICALLY MODIFIED CURCUMINS AS INHIBITORS OF ANTHRAX LETHAL FACTOR
#111Substituted 2,3-dihydro-1-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis
#112N-substituted pyridinylidenes for combating animal pests
#113Pharmaceutical compounds
#114ArylSulfonamide-based matrix metalloprotease inhibitors
#115Substituted pyridines as sodium channel blockers
#116Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
#117Therapeutic curcumin derivatives
#118Pyridine derivates and their use as Umami tastants
#119METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
#1202-(substituted-phenyl)-cyclopentane-1,3-dione compounds, and derivatives thereof
#121Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
#122Pyridine Derivatives With Umami Flavour
#123Stabilized compositions and methods of manufacture
#124γ-diketones as WNT/β-catenin signaling pathway activators
#125Very efficient process for preparing an intermediate of etoricoxib
#126Spirolactam derivatives and uses of same
#127Kinase inhibitor compounds
#128METHODS FOR TREATING COGNITIVE DISORDERS USING 3-ARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES, 3-HETEROARYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS
#129Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof
#130A PROCESS FOR PREPARATION OF INTERMEDIATES OF DONEPEZIL HYDROCHLORIDE
#131Total synthesis of redox-active 1.4-naphthoquinones and their metabolites and their therapeutic use as antimalarial and schistomicidal agents
#132CCR9 inhibitors and methods of use thereof
#133Phenicol antibacterial agents
#134β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators
#135Cinnamoyl inhibitors of transglutaminase
#136NOVEL SYNTHESIS FOR THIAZOLIDINEDIONE COMPOUNDS
#137ARYL SULFONAMIDES
#138Process for cyclooxygenase-2 selective inhibitor
#139Cyclic amide derivative
#140Arylsulfonamide CCR3 antagonists
#141Synthesis for thiazolidinedione compounds
#142Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#143Method for oxidizing alcohols
#144TRPV3 modulators
#145Arylsulfonamide based matrix metalloprotease inhibitors
#146Compositions and methods for enhancing bioenergetic status in female germ cells
#147Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#148Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process
#149Method for producing alpha-acyloxycarbonyl compound and novel alpha-acyloxycarbonyl compound
#150Arylsulfonamide based matrix metalloprotease inhibitors
#151Process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib
#152GLYCINE B ANTAGONISTS
#153Compounds useful against kinetoplastideae parasites
#154Indenone derivative and pharmaceutical composition comprising same
#1554-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#156Pyridine derivatives with umami flavour
#157COMPOUNDS AND COMPOSITIONS COMPRISING CDK INHIBITORS AND METHODS FOR TREATING CANCER
#158Curcumin analogues as zinc chelators and their uses
#159Herbicides
#160β- and γ-diketones and γ-hydroxyketones as /β-catenin signaling pathway activators
#161Method and compositions for treating amyloid-related diseases
#162ARYL SULFONAMIDES
#163Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#164Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#165Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
#166CCR9 inhibitors and methods of use thereof
#167Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
#168HEMIFUMARATE SALT
#169Bis-aryl sulfonamides
#170Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
#171Method for producing organic compound and organic compound obtained by the method
#172SUBSTITUTED ARYLOXOETHYL CYCLOPROPANECARBOXAMIDE COMPOUNDS AS VR1 RECEPTOR ANTAGONISTS
#173Small molecule inhibitors of the pleckstrin homology domain and methods for using same
#174MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#175COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE
#176Spirolactam derivatives and uses of same
#177Class of histone deacetylase inhibitors
#178Therapeutic compounds
#179Aryl sulfonamides
#180Arylsulfonamide-based matrix metalloprotease inhibitors
#181CCR9 INHIBITORS AND METHODS OF USE THEREOF
#182CCR9 inhibitors and methods of use thereof
#183Kinase inhibitor compounds
#184NOVEL COMPOUNDS
#185Arylsulfonamide CCR3 antagonists
#186Flavor molecules
#187Cell differentiation inducer
#188CCR2 INHIBITORS AND METHODS OF USE THEREOF
#189BIS-ARYL SULFONAMIDES
#190Modified chalcone compounds as antimitotic agents
#191Cinnamoyl inhibitors of transglutaminase
#192Butone derivatives useful as cooling agents
#193Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound
#194Slow release of organoboronic acids in cross-coupling reactions
#195Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
#196CCR9 inhibitors and methods of use thereof
#197Acid amide derivatives, process for their production and pesticides containing them
#198SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS
#199Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
#200Flavor molecules
#201BIS-PYRINIDIUM COMPOUNDS
#2027-substituted tetracycline compounds
#203Fatty acid amide hydrolase inhibitors
#204PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES
#205Benzophenone derivatives useful for inhibiting formation of microtubule
#206ARYL SULFONAMIDES
#207Optical recording material, chalcone type compounds and metal complexes
#208Hsp90 family protein inhibitors
#209Process for preparing ketones from alpha-oxo carboxylates and aryl bromides
#210Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
#211Pyridine ketones with herbicidal effect
#212Aryl Sulfonamides
#213Compositions and methods for modulating a kinase cascade
#214Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products
#215Aryl Sulfonamides
#2164-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
#217PYRIDYL COMPOUNDS
#218Substituted phenanthrene diketo acids and uses therefor
#219CCR9 inhibitors and methods of use thereof
#220ANTITUMOR AGENT
#221Sulphonamide Derivatives
#222INHIBITORS OF HISTONE DEACETYLASE
#223NEW EPOTHIOLONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR PHARMACEUTICAL USE
#224Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
#225ARYL SULFONAMIDES
#226Substituted pyridine herbicides
#227Iron or Cobalt-Catalyzed Carbon-Carbon Coupling Reaction of Aryls, Alkenes and Alkines With Copper Reagents
#228Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
#229Bis-aryl sulfonamides
#230Method For The Production A-Chloroalkylpyridyl Ketones And/Or The Hydrochlorides Thereof
#231Pesticidally active ketone and oxime derivatives
#232Compounds which potentiate glutamate receptor and uses thereof in medicine
#233Cell differentiation inducer
#234Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
#235Process for the production of cyclic diketones
#236COMPOUNDS WITH ACTIVITY ON MUSCARINIC RECEPTORS
#237CCR9 inhibitors and methods of use thereof
#238Materials and methods to potentiate cancer treatment
#239Arylalkanoic Acid Derivative
#240Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
#241Ligands for metals and improved metal-catalyzed processes based thereon
#242Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
#243Modified chalcone compounds as antimitotic agents
#244Cyclooxygenase-2 selective inhibitors, compositions and methods of use
#245Process for the production of cyclic diketones
#246Bis-aryl sulfonamides
#247Novel herbicides
#248Imino ether derivative compounds and drugs containing the compounds as the active ingredient
#249Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agents
#250Compounds which potentiate glutamate receptor and uses thereof in medicine
#251PROCESS FOR MAKING DONEPEZIL
#252Stable lamotrigine pharmaceutical compositions and processes for their preparation
#253Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
#2541-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
#255Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
#256Process for preparing Donepezil and its derivatives
#257CCR9 inhibitors and methods of use thereof
#258Therapeutic curcumin derivatives
#259Pyridine derivatives as potassium ion channel openers
#260Hsp90 family protein inhibitors
#261Therapeutic compounds
#262CCR2 inhibitors and methods of use thereof
#263Derivatives of 1,3-diones having a herbicidal activity
#264Condensed polycyclic compounds
#265Condensed polycyclic compounds
#266Condensed polycyclic compounds
#267Substituted enaminones, their derivatives and uses thereof
#268Compositions and methods for diagnosing and treating retinal diseases
#269Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases
#270Process and catalyst for the preparation of acetylpyridines
#271Methods and compositions for treating amyloid-related diseases
#272New substituted pyridine or piperidine compounds
#273Chalcone derivatives and their use to treat diseases
#274CCR9 inhibitors and methods of use thereof
#275Arylsulfonamide derivatives
#276Anthranilic acid amide derivatives and their pharmaceutical use
#277Pesticidally active ketone and oxime derivatives
#278Aryl sulfonamides
#279Ligands for metals and improved metal-catalyzed processes based thereon
#2801,2-Bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
#2812-Oxo-ethanesulfonamide derivates
#282Herbicides
#283Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists
#284Inhibitors of histone deacetylase
#285Ketones
#286Method and composition for rejuvinating cells, tissues organs, hair and nails
#287MCP-1 receptor antagonists and methods of use thereof
#288Metal chelates and methods of using them for time-resolved fluorescence
#289Oxidation process for the preparation of intermediates useful in the synthesis of diarylpyridines
#290Aryl sulfonamides
#291Process for preparing 1-(6-methylpyridin-3-yl)-2-[4- (methylsulphonyl)phenyl]ethanone
#292Process for the preparation of cyclic diketones
#293Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
#294Aryl sulfonamides
#295Bis-aryl sulfonamides
#296Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
#2972-Guanidino-4-heterocyclylquinazolines
#298Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
#299Novel 3-aryl-2,5-dihydroxy-1,4-benzoquinone derivatives, their preparation method and pharmaceutical compositions containing same
#300Diphenylamino ketone derivatives as MEK inhibitors